Literature DB >> 9016519

The RNA modification database.

P F Crain1, J A McCloskey.   

Abstract

The RNA modification database provides a comprehensive listing of posttranscriptionally modified nucleosides from all RNAs, and is maintained as an updated version of the initial printed report [Limbach,P.A., Crain,P.F. and McCloskey,J.A. (1994)Nucleic Acids Res. , 22, 2183-2196]. Information provided for each nucleoside includes: the RNA in which it occurs and phylogenetic distribution; common chemical name and symbol; Chemical Abstracts registry number and index name; chemical structure; initial literature citations for structural characterization or occurrence, and for chemical synthesis. The data are available through the WWW and via anonymous ftp.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016519      PMCID: PMC146386          DOI: 10.1093/nar/25.1.126

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  4 in total

Review 1.  Summary: the modified nucleosides of RNA.

Authors:  P A Limbach; P F Crain; J A McCloskey
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

Review 2.  Transfer RNA modification.

Authors:  G R Björk; J U Ericson; C E Gustafsson; T G Hagervall; Y H Jönsson; P M Wikström
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  2'-O-methyl-5-formylcytidine (f5Cm), a new modified nucleotide at the 'wobble' of two cytoplasmic tRNAs Leu (NAA) from bovine liver.

Authors:  J P Païs de Barros; G Keith; C El Adlouni; A L Glasser; G Mack; G Dirheimer; J Desgrès
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

4.  Structural characterization of U*-1915 in domain IV from Escherichia coli 23S ribosomal RNA as 3-methylpseudouridine.

Authors:  J A Kowalak; E Bruenger; T Hashizume; J M Peltier; J Ofengand; J A McCloskey
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

  4 in total
  9 in total

1.  Compilation of tRNA sequences and sequences of tRNA genes.

Authors:  M Sprinzl; C Horn; M Brown; A Ioudovitch; S Steinberg
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

2.  Methylation of the nucleobases in RNA oligonucleotides mediates duplex-hairpin conversion.

Authors:  R Micura; W Pils; C Höbartner; K Grubmayr; M O Ebert; B Jaun
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

3.  Posttranscriptional modification of tRNA in psychrophilic bacteria.

Authors:  J J Dalluge; T Hamamoto; K Horikoshi; R Y Morita; K O Stetter; J A McCloskey
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

4.  Inosine and N1-methylinosine within a synthetic oligomer mimicking the anticodon loop of human tRNA(Ala) are major epitopes for anti-PL-12 myositis autoantibodies.

Authors:  H F Becker; Y Corda; M B Mathews; J L Fourrey; H Grosjean
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

5.  A role for the MS analysis of nucleic acids in the post-genomics age.

Authors:  Daniele Fabris
Journal:  J Am Soc Mass Spectrom       Date:  2009-09-17       Impact factor: 3.109

6.  Protein degradation and dynamic tRNA thiolation fine-tune translation at elevated temperatures.

Authors:  Kshitiz Tyagi; Patrick G A Pedrioli
Journal:  Nucleic Acids Res       Date:  2015-04-13       Impact factor: 16.971

7.  The 2011 Nucleic Acids Research Database Issue and the online Molecular Biology Database Collection.

Authors:  Michael Y Galperin; Guy R Cochrane
Journal:  Nucleic Acids Res       Date:  2011-01       Impact factor: 16.971

8.  Compilation of tRNA sequences and sequences of tRNA genes.

Authors:  Mathias Sprinzl; Konstantin S Vassilenko
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

Review 9.  Above the Epitranscriptome: RNA Modifications and Stem Cell Identity.

Authors:  Francesco Morena; Chiara Argentati; Martina Bazzucchi; Carla Emiliani; Sabata Martino
Journal:  Genes (Basel)       Date:  2018-06-28       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.